Efficacy, Safety, and Pharmacokinetics by Body Mass Index Category in Phase 3/3b Long-Acting Cabotegravir Plus Rilpivirine Trials. - Elliot, Emilie R; Polli, Joseph W; Patel, Parul; Garside, Louise; Grove, Richard; Barnett, Vincent; Roberts, Jeremy; Byrapuneni, Sri; Crauwels, Herta; Ford, Susan L; Solingen-Ristea, Rodica Van; Birmingham, Eileen; et al. (Journal of Infectious Diseases, 2024)